We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+4.57%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.96B
AUM Growth
+$368M
(+23%)
Cap. Flow
+$357M
Cap. Flow
% of AUM
18.25%
Top 10 Holdings %
Top 10 Hldgs %
57.7%
Holding
95
New
25
Increased
18
Reduced
8
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amneal Pharmaceuticals
AMRX
|
+$356M |
| 2 |
AIFU
AIFU Inc
AIFU
|
+$72.5M |
| 3 |
SINA
Sina Corp
SINA
|
+$48.9M |
| 4 |
Vipshop
VIPS
|
+$29.2M |
| 5 |
DigitalBridge
DBRG
|
+$25.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MOMO
Hello Group
MOMO
|
+$124M |
| 2 |
IPXL
Impax Laboratories, Inc.
IPXL
|
+$75M |
| 3 |
Bausch Health
BHC
|
+$27.7M |
| 4 |
BZUN
Baozun
BZUN
|
+$18M |
| 5 |
VER
VEREIT, Inc.
VER
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.43% |
| 2 | Financials | 10.25% |
| 3 | Consumer Discretionary | 6.8% |
| 4 | Communication Services | 5.95% |
| 5 | Consumer Staples | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amneal Pharmaceuticals
AMRX
$5.59B
| $333M | 17% |
+20,293,351
| New | +$356M |
|
|
SINA
2
DELISTED
Sina Corp
SINA
| $142M | 7.25% |
1,676,775
+525,142
| +46% | +$48.9M |
|
3
Brookdale Senior Living
BKD
$3.57B
| $139M | 7.09% |
15,268,447
+168,558
| +1% | +$1.31M |
|
|
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
| $95.3M | 4.87% |
13,768,556
+3,000,581
| +28% | +$21.8M |
|
|
KANG
5
DELISTED
iKang Healthcare Group, Inc.
KANG
| $94.6M | 4.83% |
4,625,806
| – | – |
|
|
AIFU
6
AIFU Inc
AIFU
$196M
| $83.3M | 4.25% |
7,304
+6,235
| +583% | +$72.5M |
|
|
7
DigitalBridge
DBRG
$2.92B
| $80.4M | 4.11% |
3,222,155
+1,064,115
| +49% | +$25.4M |
|
|
SFUN
8
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $60.9M | 3.11% |
313,749
+13,954
| +5% | +$3.42M |
|
|
MOMO
9
Hello Group
MOMO
$886M
| $48.4M | 2.47% |
1,113,036
-2,989,827
| -73% | -$124M |
|
|
SOHU
10
Sohu.com
SOHU
$346M
| $45.5M | 2.32% |
1,280,779
-141,491
| -10% | -$5.1M |
|
|
11
Vipshop
VIPS
$7.01B
| $44.3M | 2.26% |
4,086,463
+2,136,666
| +110% | +$29.2M |
|
|
VER
12
DELISTED
VEREIT, Inc.
VER
| $39.1M | 2% |
1,052,204
-334,622
| -24% | -$11.7M |
|
13
Bath & Body Works
BBWI
$4.13B
| $39.1M | 2% |
1,311,544
+268,389
| +26% | +$7.75M |
|
14
Gilead Sciences
GILD
$165B
| $37.8M | 1.93% |
533,722
+185,500
| +53% | +$13.1M |
|
15
Nature's Sunshine
NATR
$369M
| $26.7M | 1.36% |
2,854,607
| – | – |
|
|
BZUN
16
Baozun
BZUN
$146M
| $20.7M | 1.06% |
378,542
-340,615
| -47% | -$18M |
|
|
CFRX
17
DELISTED
ContraFect Corporation
CFRX
| $18.8M | 0.96% |
10,625
| – | – |
|
|
COWN
18
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $18.5M | 0.94% |
1,332,674
| – | – |
|
19
CF Industries
CF
$19B
| $16.6M | 0.85% |
374,522
-209,763
| -36% | -$8.55M |
|
20
Verrica Pharmaceuticals
VRCA
$94.3M
| $15.7M | 0.8% |
+79,600
| New | +$15.6M |
|
21
MakeMyTrip
MMYT
$5.05B
| $15.6M | 0.8% |
432,834
| – | – |
|
|
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
| $13M | 0.66% |
472,532
+153,219
| +48% | +$4.61M |
|
|
ORIG
23
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $11.1M | 0.57% |
376,918
| – | – |
|
24
Criteo
CRTO
$1.11B
| $10.8M | 0.55% |
328,011
| – | – |
|
|
DOVA
25
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $8.67M | 0.44% |
289,683
-420,317
| -59% | -$11.4M |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
LWPC
MHC
Fosun International's Q2 2018 Portfolio in Review
As of Q2 2018, Fosun International held 95 positions worth $1.96B, up 23% from $1.59B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Fosun International deployed $357M of net new capital in Q2 2018, opening 25 new positions and adding to 18 existing holdings. Its largest new stake was Amneal Pharmaceuticals: 20,293,351 shares worth $333M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Hello Group, an estimated $124M trimmed.
- Fosun International's largest Q2 2018 buy was Amneal Pharmaceuticals: 20,293,351 shares worth $333M.
- Fosun International added most to AIFU Inc in Q2 2018, an estimated $72.5M increase.
- Fosun International's biggest Q2 2018 reduction was Hello Group, cutting an estimated $124M.
- Fosun International fully exited Impax Laboratories, Inc. in Q2 2018, selling an estimated $75M.
- Fosun International's ten largest holdings make up 58% of its $1.96B portfolio in Q2 2018.
- Fosun International opened 25 new positions and closed 8 in Q2 2018.
- Fosun International's portfolio value rose 23% quarter-over-quarter to $1.96B.
Based on Fosun International's 13F filing for Q2 2018, filed 13 Aug 2018.